MYC amplification
Showing 1 - 25 of 500
Phase 1, NSCLC, SCLC Trial in United States (Oral MRT-2359)
Recruiting
- NSCLC
- +6 more
- Oral MRT-2359
-
Scottsdale, Arizona
- +7 more
Dec 20, 2022
CNS Tumor, Solid Tumor Trial in Worldwide (Nivolumab and Entinostat)
Recruiting
- CNS Tumor
- Solid Tumor
- Nivolumab and Entinostat
-
Randwick, New South Wales, Australia
- +13 more
Nov 8, 2022
Hepatocellular Carcinoma, Solid Tumor, Hepatocellular Carcinoma Non-resectable Trial in San Antonio (OTX-2002, Tyrosine kinase
Not yet recruiting
- Hepatocellular Carcinoma
- +6 more
- OTX-2002
- +3 more
-
San Antonio, TexasNext Oncology
Aug 9, 2022
Advanced Cancers Trial in Boston (LY2606368)
Active, not recruiting
- Advanced Cancers
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 18, 2022
Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma, Recurrent Endometrial Endometrioid
Not yet recruiting
- Recurrent Endometrial Carcinoma
- +8 more
- BET Bromodomain Inhibitor ZEN-3694
- +7 more
- (no location specified)
Jul 15, 2023
Leukemia, Myelodysplastic Syndrome(MDS) Trial in Duarte, Houston (fadraciclib)
Recruiting
- Leukemia
- Myelodysplastic Syndrome(MDS)
-
Duarte, California
- +1 more
Apr 1, 2022
SCLC, Small Cell Cancer, Advanced Solid Tumor Trial run by the NCI (Lurbinectedin, Berzosertib)
Recruiting
- SCLC
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Tumors Trial in Chile, United States (VIP152 (BAY 1251152), VIP152 (BAY 1251152) 30 mg, Keytruda)
Recruiting
- Neoplasms
- VIP152 (BAY 1251152)
- +3 more
-
Springdale, Arkansas
- +12 more
Mar 24, 2022
Adenosquamous Carcinoma of the Pancreas Trial run by the NCI (Minnelide)
Recruiting
- Adenosquamous Carcinoma of the Pancreas
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 7, 2022
Next Generation " Pre-clinical Model for Colorectal Cancer
Recruiting
- Colorectal Cancer Metastases and Hepatocellular Carcinomas
- Tumor /metastases removal
-
Marseille, Franceap-HM hopital nord
May 17, 2022
Breast Cancer Liquid Biopsy Stratification
Active, not recruiting
- Breast Cancer
- Nucleosome positioning
-
Graz, AustriaMedical University of Graz
Mar 22, 2021
Lung Cancer, Mesothelioma Trial in Houston (Alisertib)
Completed
- Lung Cancer
- Mesothelioma
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 23, 2022
Breast Cancer Trial in Marseille (M1774, Fulvestrant injection)
Not yet recruiting
- Breast Cancer
- M1774
- Fulvestrant injection
-
Marseille, FranceInstitut Paoli Calmettes
Aug 9, 2023
Speech Perception and Amplification Benefit During Infancy
Not yet recruiting
- Hearing Loss
- +3 more
- Hearing Aids
-
Aurora, ColoradoUniversity of Colorado School of Medicine - Speech Perception Ov
Dec 14, 2022
Personal Sound Amplification Device
Completed
- Hearing Loss
- Ascending Hearing Technologies device
-
Milwaukee, WisconsinMedical College of Wisconsin
Jan 20, 2023
NSCLC Metastatic Trial in Seoul (Lazertinib, Tepotinib)
Not yet recruiting
- Non-Small Cell Lung Cancer Metastatic
-
Seoul, Gangnam-gu, Korea, Republic ofSamsung Medical Center
Oct 27, 2023
Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL) Trial in United Kingdom (SRA737)
Completed
- Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL)
-
Sutton, London, United Kingdom
- +14 more
Mar 9, 2022
stratification of High-risk Intestinal Metaplasia (GCEP2 Study)
Recruiting
- Stomach Neoplasm
- Blood Collection, processing and analyses
- +2 more
-
Stanford, California
- +7 more
Mar 13, 2023
DLBCL Trial in Qingdao (Selinexor combined with Prednisone, Etoposide, and Lenalidomide)
Not yet recruiting
- DLBCL
- Selinexor combined with Prednisone, Etoposide, and Lenalidomide
-
Qingdao, Shandong, Chinathe affiliated hospital of Qingdao University
Aug 18, 2022
Stomach Cancer, Adenocarcinoma Trial in Seoul (Durvalumab, Savolitinib)
Recruiting
- Stomach Cancer, Adenocarcinoma
-
Seoul, Korea, Republic ofSamsung Medical Center
Jan 10, 2023
Refractory Solid Tumors Trial in Seoul (pazopanib)
Completed
- Refractory Solid Tumors
-
Seoul, Korea, Republic ofSamsung Medical Center
Jun 13, 2022